StonvexLoading…
StonvexStonvexStonvexCore line items from KELYA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-28 | Annual 2024 2024-12-29 | Annual 2023 2023-12-31 | Annual 2023 2023-01-01 |
|---|---|---|---|---|
Revenue | $4.25B | $4.33B | $4.84B | $4.97B |
Operating Income | $-69.80M | $-15.10M | $24.30M | $14.80M |
Net Income | $-254.10M | $-600.00K | $36.40M | $-62.50M |
EPS (Diluted) | $-7.24 | $-0.02 | $0.98 | $-1.64 |
Total Assets | $2.25B | $2.63B | $2.58B | $2.66B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $33.00M | $39.00M | $125.80M | $153.70M |
Free Cash Flow OCF − CapEx | $114.10M | $15.80M | $61.40M | $-88.30M |
Shares Outstanding | 35.10M | 35.50M | 36.30M | 38.10M |